Similar articles for PMID: 23002160

Year	Number of Results
1999	1
2000	2
2002	3
2004	2
2005	3
2006	2
2007	4
2008	4
2009	5
2010	5
2011	4
2012	11
2013	5
2014	3
2015	9
2016	9
2017	7
2018	6
2019	8
2020	3
2021	1
2023	3
2024	0

1

Influence of FCGR3A genotype on the therapeutic response to rituximab in rheumatoid arthritis: an observational cohort study.

Kastbom A, Cöster L, Arlestig L, Chatzidionysiou A, van Vollenhoven RF, Padyukov L, Rantapää-Dahlqvist S, Saevarsdottir S. Kastbom A, et al. BMJ Open. 2012 Sep 22;2(5):e001524. doi: 10.1136/bmjopen-2012-001524. Print 2012. BMJ Open. 2012. PMID: 23002160 Free PMC article.

2

The 158VV Fcgamma receptor 3A genotype is associated with response to rituximab in rheumatoid arthritis: results of an Italian multicentre study.

Quartuccio L, Fabris M, Pontarini E, Salvin S, Zabotti A, Benucci M, Manfredi M, Biasi D, Ravagnani V, Atzeni F, Sarzi-Puttini P, Morassi P, Fischetti F, Tomietto P, Bazzichi L, Saracco M, Pellerito R, Cimmino M, Schiavon F, Carraro V, Semeraro A, Caporali R, Cavagna L, Bortolotti R, Paolazzi G, Govoni M, Bombardieri S, De Vita S. Quartuccio L, et al. Ann Rheum Dis. 2014 Apr;73(4):716-21. doi: 10.1136/annrheumdis-2012-202435. Epub 2013 Mar 16. Ann Rheum Dis. 2014. PMID: 23505228

3

Impact of FCGR2A R131H, FCGR3A F158V and FCGR3B NA1/NA2 polymorphisms on response to Fc-containing TNF inhibitors in Tunisian rheumatoid arthritis patients.

Mahmoud I, Moalla M, Ben Tekaya A, Bouden S, Rouached L, Tekaya R, Saidane O, Gorji Y, Elleuch M, Laatar A, Hamdi W, Abdelmoula L, Sfar I. Mahmoud I, et al. Drug Metab Pers Ther. 2023 Mar 16;38(2):155-162. doi: 10.1515/dmpt-2022-0176. eCollection 2023 Jun 1. Drug Metab Pers Ther. 2023. PMID: 36919284

4

FCGR2A/FCGR3A Gene Polymorphisms and Clinical Variables as Predictors of Response to Tocilizumab and Rituximab in Patients With Rheumatoid Arthritis.

Jiménez Morales A, Maldonado-Montoro M, Martínez de la Plata JE, Pérez Ramírez C, Daddaoua A, Alarcón Payer C, Expósito Ruiz M, García Collado C. Jiménez Morales A, et al. J Clin Pharmacol. 2019 Apr;59(4):517-531. doi: 10.1002/jcph.1341. Epub 2018 Nov 20. J Clin Pharmacol. 2019. PMID: 30457672

5

Association between functional FCGR3A F158V and FCGR2A R131H polymorphisms and responsiveness to rituximab in patients with autoimmune diseases: a meta-analysis.

Lee YH, Song GG. Lee YH, et al. Pharmacogenomics J. 2023 Nov;23(6):210-216. doi: 10.1038/s41397-023-00308-9. Epub 2023 May 6. Pharmacogenomics J. 2023. PMID: 37149714 Review.

6

Involvement of Fcgamma receptor IIIA genotypes in susceptibility to rheumatoid arthritis.

Nieto A, Cáliz R, Pascual M, Matarán L, García S, Martín J. Nieto A, et al. Arthritis Rheum. 2000 Apr;43(4):735-9. doi: 10.1002/1529-0131(200004)43:4<735::AID-ANR3>3.0.CO;2-Q. Arthritis Rheum. 2000. PMID: 10765917 Free article.

7

Association between the functional FCGR3A F158V and FCGR2A R131H polymorphisms and responsiveness to biologics in rheumatoid arthritis patients: A meta-analysis.

Lee YH, Song GG. Lee YH, et al. Int J Rheum Dis. 2023 Jul;26(7):1295-1304. doi: 10.1111/1756-185X.14719. Epub 2023 Apr 28. Int J Rheum Dis. 2023. PMID: 37114884

8

Effect of Fcγ-receptor 3a (FCGR3A) gene polymorphisms on rituximab therapy in Hungarian patients with rheumatoid arthritis.

Pál I, Szamosi S, Hodosi K, Szekanecz Z, Váróczy L. Pál I, et al. RMD Open. 2017 Nov 1;3(2):e000485. doi: 10.1136/rmdopen-2017-000485. eCollection 2017. RMD Open. 2017. PMID: 29177079 Free PMC article.

9

Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor FcgammaRIIIa gene.

Cartron G, Dacheux L, Salles G, Solal-Celigny P, Bardos P, Colombat P, Watier H. Cartron G, et al. Blood. 2002 Feb 1;99(3):754-8. doi: 10.1182/blood.v99.3.754. Blood. 2002. PMID: 11806974 Free article. Clinical Trial.

10

The 158V polymorphism of Fc gamma receptor type IIIA in early rheumatoid arthritis: increased susceptibility and severity in male patients (the Swedish TIRA project).

Kastbom A, Ahmadi A, Söderkvist P, Skogh T. Kastbom A, et al. Rheumatology (Oxford). 2005 Oct;44(10):1294-8. doi: 10.1093/rheumatology/kei010. Epub 2005 Jul 5. Rheumatology (Oxford). 2005. PMID: 15998631

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

82 results

Results by year